2018
DOI: 10.1096/fj.201802004r
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo

Abstract: Increased levels of the calcium‐binding protein neuronal calcium sensor 1 (NCS1) predict an unfavorable patient outcome in several aggressive cancers, including breast and liver tumors. Previous studies suggest that NCS1 overexpression facilitates metastatic spread of these cancers. To investigate this hypothesis, we explored the effects of NCS1 overexpression on cell proliferation, survival, and migration patterns in vitro in 2‐ and 3‐dimensional (2/3‐D). Furthermore, we translated our results into an in vivo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 60 publications
0
19
1
Order By: Relevance
“…We found that this mechanism of NCS1 up‐regulation is conserved in the pathophysiology of human breast cancer, and we showed that NCS1 has essential functions for cell survival and migration through altering intracellular Ca 2+ signaling and Akt signaling. The novel finding that extracellular stressors lead to NCS1 up‐regulation helps us understand how high NCS1 expression leads to more aggressive behavior of tumor cells and worse patient outcome (Apasu et al , 2019; Moore et al , 2017; Schuette et al , 2018). In conclusion, we describe a novel role for NCS1 as stress response protein linking the tumor microenvironment and cancer progression.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We found that this mechanism of NCS1 up‐regulation is conserved in the pathophysiology of human breast cancer, and we showed that NCS1 has essential functions for cell survival and migration through altering intracellular Ca 2+ signaling and Akt signaling. The novel finding that extracellular stressors lead to NCS1 up‐regulation helps us understand how high NCS1 expression leads to more aggressive behavior of tumor cells and worse patient outcome (Apasu et al , 2019; Moore et al , 2017; Schuette et al , 2018). In conclusion, we describe a novel role for NCS1 as stress response protein linking the tumor microenvironment and cancer progression.…”
Section: Resultsmentioning
confidence: 99%
“…Here, we focus on the Ca 2+ ‐binding protein neuronal calcium sensor 1 (NCS1), which shares multiple characteristics with the S100 protein family. Like S100 proteins, NCS1 belongs to the EF‐hand superfamily of Ca 2+ ‐binding proteins (Burgoyne, 2007; Donato et al , 2013), is increased in cancerous tissues, and contributes to a more aggressive phenotype of these tumors (Apasu et al , 2019; Moore et al , 2017; Moore et al , 2018; Schuette et al , 2018). It binds Ca 2+ with high affinity and contains four EF‐hand domains, three of which bind Ca 2+ , and one of which, in the N‐terminal domain, is unable to bind Ca 2+ (Boeckel and Ehrlich, 2018; Bourne et al , 2001).…”
Section: Introductionmentioning
confidence: 99%
“…55,56 A role for NCS1 in regulating neuronal morphology is supported by previous studies describing that NCS1 enhances neurite outgrowth [16][17][18] and synaptic transmission, specifically neurotransmitter release, LTP, and LTD. [12][13][14][15] Similarly, NCS1 regulates exocytosis in adrenal chromaffin cells, 57 morphology of cardiomyocytes, 52 and motility of cancer cells. 50,58 The gross morphology of the brain has been reported to be unaltered in Ncs1 −/− mice. 21 Reduced dendritic morphology in Ncs1 −/− mice may be due to several, not mutually exclusive mechanisms.…”
Section: Ncs1 As a Modulator Of Gene Expressionmentioning
confidence: 99%
“…Abnormalities in the expression and function of NCS-1, as well as hereditary mutations in its gene, are associated with neurodegenerative and neuropsychiatric diseases, including schizophrenia, autism, Alzheimer's disease, and Parkinson's disease [23]. In addition, NCS-1 is aberrantly expressed in certain cancers, and the level of its expression correlates with tumor aggressiveness and patients' survival rates [24,25].…”
Section: Introductionmentioning
confidence: 99%